Logo Logo Logo Logo Logo
  • Home
  • Expertise
  • Consulting Services
  • Our Platforms
  • News
  • Careers
  • Contact
  • Home
  • Expertise
  • Consulting Services
  • Our Platforms
  • News
  • Careers
  • Contact

L’actualité Prioritis

06 October, 2021 in News
Les nouvelles indications en oncologie peu accessibles au patient français
09 October, 2018 in News
Evaluation du médicament au Japon dans Prismaccess
11 June, 2018 in News
Prioritis at ISPOR Baltimore
26 February, 2018 in News
Spain, a new financing model for high economic-impact medicines
19 February, 2018 in News
Données Prismaccess dans une étude de l’INCa
31 January, 2018 in News
RWD and RWE will play an increasing role in health care decisions
09 January, 2018 in News
PRIORITIS heads a market access training at Paris-Dauphine University
30 November, 2017 in News
Peru’s HTA Agency reports in Prismaccess & Evalumade platforms
23 October, 2017 in News
Singapore’s HTA decisions in Prismaccess and Evalumade
20 October, 2017 in News
ISPOR 20th Annual European Congress
An IQVIA Business

logo
Contact us

IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and contract research services to the life sciences industry dedicated to delivering actionable insights. Learn more at www.iqvia.com

Prioritis United Kingdom
United Kingdom
Prioritis Ltd
221 Pentonville Road King’s Cross
London N1 9JY – United Kingdom
tel. +44 7908 126 651
contact@prioritis.com
Prioritis France
France
Prioritis SAS
12 av Victor Hugo
75116 Paris
tel. +33 1 45 00 25 25 contact@prioritis.com